Event in Progress:
Discover the latest content that has just been published on Research Tree
3M delivered a mixed set of results amidst the challenging economic environment with supply chain disruptions, inflation, and slowing growth. The company did manage to surpass the revenue expectations of Wall Street but missed out on meeting earnings expectations. Because of Covid-related disruptions, 3M saw a significant slowing in China and modernizing demand over industrial markets. The company recently announced restructuring its manufacturing operations as it saw the demand trends extend in
Companies: 3M Co (MMM:NYSE)3M Company (MMM:NYS)
Baptista Research
3M delivered a mixed set of results for the last quarter as it failed to meet revenue expectations of Wall Street but managed an earnings beat. Transportation, Electronics, Safety, Industrial, Consumer, and Health Care all experienced organic growth of 3%. Every business segment produced margins higher than 21%, with noteworthy margin growth in the safety, industrial, transportation, and electronics sectors. This is what helped them deliver an earnings beat. The management keeps investing in gro
Apart from being known as one of the most innovative companies in today’s times, 3M also has a strong reputation of successful restructuring and cost management which has helped the industrial conglomerate survive through many challenging business cycles. The company delivered solid quarterly results surpassing Wall Street expectations on all counts while navigating the continued inflationary pressures and supply chain challenges. The company continues to benefit from strong spending discipline,
Companies: 3M Company (MMM:NYS)Mining, Minerals & Metals plc (MMM:LON)
3M had a strong start to 2022 in a challenging global environment. The company performed well in the first quarter while managing supply chain disruptions, inflation, and geopolitical pressures. 3M delivered a 2% organic growth in the quarter along with sequential margin improvement, and strong cash generation. Demand is strong overall, though the global economic outlook has weakened due to challenges in certain end markets, an ever-changing Covid-19 impact, and recent geopolitical events. 3M co
3M recent revenue performance has been strong on account of the healthcare business, particularly the increase in respiratory demand due to the Omicron variant's impact. The company’s organic growth has been slow and it has witnessed an adverse margin impact of supply chain disruptions, inflation, and Covid-19 but its cost control measures have been strong. 3M's selling price actions gained traction in the last quarter with a year-over-year increase of 2.6%. The company has a strong cash positio
3M had a strong fourth quarter, capping off a fairly decent 2021 despite a rapidly changing external environment. Its revenue in the quarter exceeded expectations across the board, including an increase in respiratory demand due to the Omicron variant's impact. The company’s organic growth has been slower than expected, at 1%, down from 6% in the previous quarter, with earnings being boosted by a strong December execution and a lower-than-expected tax rate. It is worth highlighting that 3M saw g
3M reported another solid quarter with a 7.1% top-line growth and a 6.3% increase year-on-year in organic revenues, comfortably surpassing Wall Street expectations. The company saw a high-single-digit growth across all key segments, particularly the core Safety and Industrial segment which grew by 7.2% and the Consumer segment which grew by 8.1%. However, the company continued to face inflationary pressure including higher costs related to polypropylene, ethylene, resins and labor. The global se
3M managed to deliver yet another all-around beat but its outlook for the rest of the year has been disappointing. The industrial conglomerate, known to produce everything from post-its and adhesives to industrial sandpaper and N95 masks saw a recovery in many of its key segments but has been facing strong inflationary pressures. 3M witnessed surging raw material and freight costs which are likely to lower its 2021 margins. Moreover, the company, which is the largest American producer of N95 mas
Research Tree provides access to ongoing research coverage, media content and regulatory news on 3M Company. We currently have 8 research reports from 2 professional analysts.
Strix has reported FY23 results to 31 December 2023 with adjusted PAT of £20.1m, in line with our updated forecast and company guidance provided in January. Revenue grew 35.2% to £144.6m, benefitting from the full year inclusion of the Billi acquisition, albeit slightly below our forecast of £151.0m. Its core Kettle Controls division also performed robustly, growing 2.7%, ahead of the broader market and indicating market share gain. Recent acquisitions have noticeably improved the Group’s growth
Companies: Strix Group PLC
Zeus Capital
Companies: Yu Group PLC
Liberum
Companies: FOG PEB KBT EMR TIME GETB JNEO
Cavendish
Cohort announces that its subsidiary SEA (Systems Engineering and Assessment Ltd.) has been awarded a major contract by the UK’s Ministry of Defence to provide Electronic Warfare Counter Measures (Increment 1a) (EWCM 1a) to the Royal Navy with a total value of at least £135m. This includes provision and support of SEA’s Trainable Decoy Launcher System, Ancilia. At the FY 24 interim results Cohort had commented on an overall “increased tempo” of order intake. The Group reported a closing order b
Companies: Cohort plc
Equity Development
The focus of Hardman & Co Research is on the nine quoted Infrastructure Investment Companies (IICs) and on the 22 Renewable Energy Infrastructure Funds (REIFs): the stocks analysed are all members of the Association of Investment Companies (AIC). We are updating our publication of January 2023, assessing both the lacklustre share price performances during 2023 and the key issues, including interest rates, inflation and power prices. As a 31-strong group, its combined market capitalisation is no
Companies: AEIT ROOF DGI9 INPP GSF SEIT USFP HICL ORIT BSIF TRIG NESF SEQI HEIT GRP GCP FSFL 3IN AERI PINT RNEW BBGI GSEO DORE TENT GRID CORD HGEN AEET
Hardman & Co
Companies: Luceco PLC
Positives emerged, particularly in H2, as the recovery commenced within the kettle controls market. Billi was the architect of the revenue improvement, with LAICA also delivering a double-digit increase in the top line. Margins improved, notwithstanding a change in the mix. Encouragingly, investor concerns on debt were allayed with the careful management of cash, and latterly as bankers raised the net debt/EBITDA covenant to 2.75x. With further emphasis on costs and cash conservation and a lik
Quadrise continues to advance towards commercial revenues for its innovative fuel and biofuel technologies, with each of its projects approaching key milestones in 2024. Preparatory steps for the MSC Shipmanagement (MSC) fuel trials are now complete and fuel supply agreements are nearing finalisation. Quadrise will achieve its first licensing revenues on the successful completion of Valkor’s project financing (timing uncertain). Quadrise also successfully concluded its Morocco trial, paving the
Companies: Quadrise PLC
Edison
Companies: FOG TND BVXP ACC HDD
Companies: Michelmersh Brick Holdings PLC
Canaccord Genuity
Companies: Flowtech Fluidpower plc
Judges Scientific is a group involved in the buy and build of scientific instrumentation businesses. Testament to the strength of its highly engineered offer and global diversified customer base, total revenue increased an impressive 20.2% to £136.1m (organic +15%), with adj. PBT +7.5% to £31.7m (FY2022: £28.3m), 3.1% ahead of our estimate of £30.5m. Fully diluted (FD) adjusted EPS increased a more muted 2.6% (impacted by anticipated tax headwinds) to 368.5p (basic adj EPS 374.5p), 3.4% ahead of
Companies: Judges Scientific plc
WHIreland
Companies: BILN IGP RBN SBTX
Gelion has reported in line H1 FY24 results that demonstrate continued strong cash management and steady progress in its pursuit of next generation lithium-sulphur battery technologies. Encouraging early test results justify last year’s IP acquisitions and validate Gelion’s Li-S battery technology plan, with additional progress expected to be reported in H2 alongside its pursuit of a strategic partner for its planned Advanced Commercial Prototyping Centre (ACPC) facility in Australia. There is a
Companies: Gelion PLC
Forterra’s FY23 (to 31 December) earnings were slightly higher than guidance, which was raised in January, with resilient pricing partly offsetting a steep fall in demand among its main end users, large housebuilders. Our estimates are broadly unchanged, other than reflecting a more conservative stance on the final dividend. Despite a cautious tone in the outlook statement, we believe the largest housebuilders may now rebound more strongly than smaller peers.
Companies: Forterra Plc
Progressive Equity Research
Share: